Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ZOLEDRONATE Cause Malignant neoplasm progression? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Malignant neoplasm progression have been filed in association with ZOLEDRONATE. This represents 20.4% of all adverse event reports for ZOLEDRONATE.

11
Reports of Malignant neoplasm progression with ZOLEDRONATE
20.4%
of all ZOLEDRONATE reports
6
Deaths
3
Hospitalizations

How Dangerous Is Malignant neoplasm progression From ZOLEDRONATE?

Of the 11 reports, 6 (54.5%) resulted in death, 3 (27.3%) required hospitalization.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ZOLEDRONATE. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does ZOLEDRONATE Cause?

Osteonecrosis of jaw (14) Pyrexia (7) Metastases to bone (6) Death (5) Hypocalcaemia (5) Malaise (5)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Related Pages

ZOLEDRONATE Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression ZOLEDRONATE Demographics